Kuros Back?
Seite 1 von 2 Neuester Beitrag: 10.05.24 12:00 | ||||
Eröffnet am: | 25.09.19 14:02 | von: Zamorano1 | Anzahl Beiträge: | 32 |
Neuester Beitrag: | 10.05.24 12:00 | von: isostar100 | Leser gesamt: | 22.392 |
Forum: | Börse | Leser heute: | 8 | |
Bewertet mit: | ||||
Seite: < 1 | 2 > |
http://e3.marco.ch/publish/kuros/1091_712/...82019_PR_final_clean.pdf
Gibts noch jemanden hier auf der Lauer?
https://kurosbio.com/resources/...rts-results-for-the-full-year-2021/
Überzeugende Zahlen oder wie ist eure Einschätzung?
https://kurosbio.com/resources/...s-for-the-first-six-months-of-2022/
https://kurosbio.com/resources/...sales-in-first-nine-months-of-2022/
https://www.ariva.de/news/...-results-for-the-full-year-2022-10586867
kurios: die marketingkosten sind gleich hoch wie die verkaufseinnahmen.
grundsatzentscheidung bei kuros: fibrin wird quasi aufgegeben, fokus auf magnet-os.
Chris Fair, Chief Executive Officer of Kuros, said: “We are encouraged by the excellent results obtained with MagnetOs in both trials, and this, coupled with a recent interbody FDA clearance of MagnetOs, means that we now have level one clinical evidence of a best-in-class product to treat even difficult-to-heal patients. As a result, we have made the decision not proceed to Phase 3 with Fibrin-PTH and focus our investment and resources on the MagnetOs bone graft family of products. We are fortunate to have growing robust sales from MagnetOs to readily support our ongoing commercial and clinical operations.”
https://www.ariva.de/news/...es-results-from-two-prospective-11097066
https://www.cash.ch/news/top-news/...ng-den-verlust-verringert-692721